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Abstract
Background: Multi-walled carbon nanotubes (MWCNTs) are widely used in many disciplines due to their unique
physical and chemical properties. Therefore, some concerns about the possible human health and environmental
impacts of manufactured MWCNTs are rising. We hypothesized that instillation of MWCNTs impairs pulmonary
function in C57BL/6 mice due to development of lung inflammation and fibrosis.
Methods: MWCNTs were administered to C57BL/6 mice by oropharyngeal aspiration (1, 2, and 4 mg/kg) and we
assessed lung inflammation and fibrosis by inflammatory cell infiltration, collagen content, and histological
assessment. Pulmonary function was assessed using a FlexiVent system and levels of Ccl3, Ccl11, Mmp13 and IL-33
were measured by RT-PCR and ELISA.
Results: Mice administered MWCNTs exhibited increased inflammatory cell infiltration, collagen deposition and
granuloma formation in lung tissue, which correlated with impaired pulmonary function as assessed by increased
resistance, tissue damping, and decreased lung compliance. Pulmonary exposure to MWCNTs induced an
inflammatory signature marked by cytokine (IL-33), chemokine (Ccl3 and Ccl11), and protease production (Mmp13)
that promoted the inflammatory and fibrotic changes observed within the lung.
Conclusions: These results further highlight the potential adverse health effects that may occur following MWCNT
exposure and therefore we suggest these materials may pose a significant risk leading to impaired lung function
following environmental and occupational exposures.
Keywords: MWCNT, pulmonary fibrosis, pulmonary function, Ccl3, Ccl11, Mmp13, IL-33, Flexivent, Raman
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Background
The use of nanomaterials has been prominent in recent
years due to their diverse properties and applications.
Carbon nanotubes, in particular, possess the potential
for numerous modifications and display unique physical
and chemical properties, making them the ideal choice
for product development in technological and biomedi-
cal industries [1]. Despite increasing use of carbon
nanotubes, there is limited research on the potentially
detrimental effects to human health and safety. In exist-
ing studies of carbon nanotube exposure in animal
models, multi-walled carbon nanotubes (MWCNT) have
been shown to potentiate allergic, inflammatory and
fibrotic pulmonary responses. These effects have been
associated with significant increases in pro-inflammatory
cytokines such as IL-5, IL-6, IL-33 and others [2]. Inoue
et al. determined that MWCNT exposure augments pul-
monary inflammation induced by initial LPS activation
of cytokines [3]. Post-exposure periods as early as 7
days have demonstrated increased collagen accumula-
tion, development of granulomas and fibrosis in murine
lungs exposed to MWCNT levels comparable to human
exposure levels [4]. Ma-Hock et al. showed similar data
with MWCNT inhalation in rats 90 days post-exposure
[5]. Development of fibrotic tissue in lungs of mice
exposed to MWCNT has been shown to correlate with
increased macrophage and epithelial cell mediated
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production of platelet derived growth factor AA (PGDF-
AA), a major mediator of pulmonary fibrosis [6]. In
addition to inducing adverse pulmonary effects, expo-
sure to MWCNTs has also been shown to augment pre-
existing allergic responses. Ryman-Rassmusen et al.
demonstrated that mice exposed to MWCNT following
ovalbumin sensitization developed significantly increased
airway fibrosis and lung inflammation compared to mice
that were not treated with MWCNTs but challenged
with ovalbumin [7]. This suggests that pre-existing aller-
gic conditions may predispose individuals to adverse
effects of MWCNTs [7]. While these data validate the
potential adverse effects, few studies have been con-
ducted to confer these findings in the context of pul-
monary physiology. A recent study by North et al.
demonstrates altered pulmonary function with exposure
to particulate matter [8]. It was shown that in animals
challenged with ovalbumin, exposure to ambient air par-
ticles augments airway resistance and hyperresponsive-
ness [8]. While MWCNTs are known to augment pre-
existing allergic conditions, they are also able to inde-
pendently produce adverse pulmonary responses. How-
ever, the effects of MWCNTs on pulmonary function
have yet to be determined.
Pulmonary function testing is a valuable tool to evalu-
ate phenotypic characteristics of mouse respiratory dis-
ease that might be caused by nanoparticle exposure.
Hamilton et al. have demonstrated that BALB/c mice
exposed to carbon nanoparticles had increased airway
hyperresponsiveness as measured by changes in PenH
using barometric whole body plethysmography [9]. This
study suggests potential for nanoparticles to influence
pulmonary function; however, alterations in specific
lung function parameters have not been reported. The
FlexiVent provides a method to directly measure pul-
monary function via the use of preprogrammed ventila-
tor and system-specific maneuvers such as forced
oscillation technique (FOT) [10]. FOT measures the
respiratory impedance (Z) which is considered a detailed
measurement of pulmonary mechanics [11]. FOT is an
administration of small pressure oscillations at the air-
way opening using an external generator while simulta-
neously recording the oscillatory pressure and flow
signals [12,13]. Respiratory impedance (Z) is a complex
quantification represented by two components: respira-
tory resistance (Rrs) and reactance (Xrs). Rrs is derived
from airways and lung tissue resistance, whereas Xrs is
determined by the inertial (I) and elastic (E) properties
of the respiratory system [14]. This technique provides a
means of distinguishing central airways from peripheral
airways and lung parenchyma.
In the current study, we tested the hypothesis that
instillation of MWCNTs impairs pulmonary function in
C57BL/6 mice due to development of lung inflammation
and fibrosis. As will be shown, mice instilled with
MWCNTs exhibited increased inflammatory cell infiltra-
tion, collagen deposition, and granuloma formation that
led to deteriorating pulmonary function 30 days follow-
ing instillation. Pulmonary exposure of MWCNTs
induces an inflammatory signature marked by cytokine
(IL-33), chemokine (Ccl3 and Ccl11), and protease
(Mmp13) production which collectively promote inflam-
matory and fibrotic changes within the lung.
Results
MWCNT characterization
Our electron microscopy studies revealed that the
MWCNTs used in this study were several microns long
with a bi-modal diameter distribution exhibiting peaks
at ~12.5 and 25 nm (Figures 1A, B &1C). In MWCNT
Raman spectra, the presence of strong disorder band
~1350 cm-1 indicates the defective nature of the
Figure 1 Characterization of MWCNT in Dry Powder Form.
Characterization of multi-walled carbon nanotubes was determined
using electron microscopy and Raman spectroscopy. (A & C) The
diameter of the MWNCTs was determined by measuring individual
nanotubes visualized by TEM. (B) This SEM image shows a bundle of
MWCNTs, with individual nanotubes indicated by arrows. The length
of individual nanotubes was determined to be several μm long
using SEM. (D) The Raman spectrum of MWCNT obtained using
514.5 nm laser excitation. The presence of strong disorder band (ID/
IG peak ratio) suggests the existence of structural defects as
determined by Raman spectroscopy.
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nanotubes. Specifically, the ratio (R = ID/IG) between the
intensity of disorder band (D-band) and graphite-like
band (G-band) was found to be 0.65 (Figure 1D). The
elemental analysis indicated presence of Fe catalyst in
MWCNT samples (Additional File 1: Figure S1 & S2).
Further, the TGA studies showed that the MWCNT
samples posses ~ 5 wt% of Fe catalyst (Additional File 1:
Figure S1 & S2). The surface area of the MWCNTs was
determined to be 113.103 m2/g, based on the BET equa-
tion. The pore volume of the MWCNTs, defined as the
ratio of the MWCNTs’ air volume to their total volume,
was determined to be 0.688 cm3/g utilizing the BJH
method. The hydrodynamic sizes of the MWCNT sus-
pension displayed two peaks, a major one at 200 ± 50
nm and another at 1,000 ± 150 nm (Figure 2A). The lar-
ger sized peak was caused by the bundling of the nano-
tubes through hydrophobic interaction and pi-stacking.
The MWCNT suspension displayed a zeta potential of
-44.6 mV, suggesting a very stable colloidal state of the
nanomaterial. The IEP of the MWCNT suspension was
measured to be pH = 3.5 (Figure 2B).
MWCNTs Induce Pulmonary Inflammation and Granuloma
Formation in C57BL/6 Mice
To investigate the inflammatory effects of MWCNT
exposure that may be associated with function changes,
C57BL/6 mice treated with 10% saline/surfactant or
increasing doses of MWCNTs underwent bronchoalveo-
lar lavage (BAL) 30 days post-exposure. Differential cell
counts obtained from BAL demonstrated persistent
inflammation with pulmonary infiltration of multiple
cell types (Table 1). Statistically significant elevations in
macrophage, epithelial cell, and neutrophil numbers
were observed in animals exposed to the highest dose
MWCNT (4 mg/kg), along with an overall increase in
total cell recruitment (p < 0.001). Exposure to both the
1 and 2 mg/kg MWCNT treatments displayed signifi-
cant increases in epithelial and neutrophil cell counts (p
< 0.05) compared to mice treated with vehicle. Increases
in eosinophil numbers were observed with MWCNT
exposure, but did not reach significance compared to
control mice. Histological evaluation of lung sections
confirmed the altered inflammatory cell profile and
additionally revealed increased collagen deposition as
well as changes in lung morphology following MWCNT
aspiration. Quantification of collagen content within
lung tissue demonstrated a significant increase in
MWCNT (4 mg/kg) exposed mice compared to naïve
mice (Figure 3). However, no statistically significant dif-
ference was found between vehicle and MWCNT trea-
ted mice, nor was there a statistical difference between
naïve and vehicle treated mice. Oro-pharyngeal aspira-
tion of MWCNTs resulted in wide distribution of gran-
ulomatous foci containing MWCNT agglomerates and
MWCNT laden macrophages throughout the lung par-
enchyma (Figure 4B) as well as peribronchiolar and peri-
vascular regions (Figure 4B, D &4F). In contrast, mice
exposed to vehicle control did not display any inflam-
mation or granulomas (Figure 4A, C, &4E).
Instillation of MWCNTs in C57BL/6 Mice Elicits Dose-
Dependent Changes in Pulmonary Function
To determine if MWCNT exposure elicits any physiolo-
gically relevant toxicity, we examined pulmonary func-
tion in C57BL/6 mice following instillation of vehicle, 1,
2, or 4 mg/kg of MWCNTs. As shown in Figure 5, the
snapshot perturbation (Figure 5A, B &5C) in C57BL/6
mice revealed a dose-dependent pulmonary response to
MWCNT instillation with a statistically significant
increase in R compared to vehicle treated and naïve
mice (Figure 5A). Further, MWCNT instillation led to a
statistically significant decrease in C as compared to the
naïve mice, but this did not reach significance as com-
pared to vehicle treated mice (Figure 5C). The quick-
prime 3 perturbation (Figure 5D, E &5F) further demon-
strated a moderate dose dependent pulmonary response
to MWCNTs with increases in Rn, G, and eta following
pulmonary instillation of 1, 2, or 4 mg/kg MWCNTs.
Mice treated with 4 mg/kg MWCNTs displayed signifi-
cant increases in tissue damping (G) (Figure 5E) and
hysteresivity (eta) (Figure 5F) compared to both the
naïve and vehicle groups. Meanwhile, both G and eta
displayed a significant dose dependent response to
MWCNTs.
The PVr-P loop perturbations showed dose-dependent
decreases in the deflating PV loop (K) (Figure 6B) and
Figure 2 Characterization of MWCNT in Suspension. The size
and charge characteristics of the MWCNTs were determined in a
suspension of 10% surfactant saline. (A) The size of MWCNT bundles
in suspension was determined by dynamic light scattering. (B) The
zeta potential and isoelectric point (indicated by the arrow) were
determined for the MWCNTs suspended in 10% surfactant saline
solution.
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static compliance (Cst) (Figure 6C). Both reductions of
K and Cst were statistically significant in the 4 mg/kg
treated group compared to naïve mice; however, the
change in Cst was not statistically different from vehicle
control. As expected, Est showed the opposite trend as
Cst, but differences between treatment groups were not
statistically significant. In contrast, the area between the
limbs of the PV loop displayed a statistically significant
increase in the 4 mg/kg treated mice compared to the
vehicle group (Figure 6E), but was not statistically differ-
ent from naïve or other MWCNT treated mice. No sta-
tistically significant differences were found between
naïve and vehicle treated mice in Figure 5 and 6.
Ccl3, Ccl11, Mmp13 and IL-33 are Increased in the Lungs
and BALF of C57BL/6 Mice instilled with MWCNTs
To assess potential mechanisms involved in MWCNT
directed pulmonary inflammation, fibrosis and alteration
of lung function, we employed a mouse fibrosis PCR array
to investigate the expression of 84 keys genes associated
with fibrosis. Gene expression was analyzed using unla-
vaged lung tissue homogenates from mice exposed to
vehicle or 4 mg/kg MWCNT. Messenger RNA levels of
multiple fibrotic mediators that were up- or down-regu-
lated > 2 fold in MWCNT instilled mice are shown in
Table 2. To verify PCR array data on dose dependent
changes in gene expression induced by MWCNT expo-
sure, mRNA levels of Ccl3, Ccl11, and Mmp13 were ana-
lyzed in vehicle, 1, 2, and 4 mg/kg MWCNT instilled
mice. As shown in Figure 7, mRNA levels of Ccl3, Ccl11,
and Mmp13 were increased in all MWCNT-treated
groups with a statistically significant increase observed in
the 2 mg/kg MWCNT group compared to vehicle control.
In addition to mRNA levels of Ccl3, Ccl11, and
Mmp13; we assessed protein levels of chemokines, Ccl3
(Mip1a) and Ccl11 (eotaxin), and activity levels of
Mmp13 in BALF of vehicle and MWCNT instilled mice.
Similar to mRNA levels, both Ccl3 and Ccl11 levels
were elevated in MWCNT instilled mice but did not
reach significant levels when compared to vehicle trea-
ted mice (Figures 8A &8B). Thirty days post-MWCNT
instillation, we observed dose-dependent increases in
Mmp13 levels as well as collagenase activity in BALF
from MWCNT instilled mice with statistically significant
increases in the 4 mg/kg MWCNT instilled mice com-
pared to vehicle control (Figures 8C &8D).
To further investigate mechanisms involved in the
inflammatory response, we identified IL-33, a novel alar-
min and Th2 cytokine, as a potential mediator in
MWCNT induced pulmonary inflammation. While no
dose dependent change was evident, gene expression ana-
lysis of lung tissue from mice 30 days post-exposure to 1,
2, or 4 mg/kg MWCNTs demonstrated a statistically sig-
nificant > 2-fold induction in Il-33 (Figure 9A). Similarly,
assessment of IL-33 protein expression in BALF exhibited
a statistically significant increase for all dose groups com-
pared to the vehicle control (Figure 9B). There were no
significant differences in Il-33 gene expression or protein
levels between MWCNT dose groups.
Discussion
Pulmonary toxicity of MWCNTs has been reported in both
mouse and rat models [15-17]. Instillation of MWCNT into
Table 1 Effect of MWCNT instillation on pulmonary cell populations in C57BL/6 mice
Treatment Macrophages (×103) Epithelial Cells (×103) Neutrophils (×103) Eosinophils (×103) Lymphocytes
(×103)
Total Cells
(×103)
Vehicle 113.71 ± 11.51 22.60 ± 3.80 0.18 ± 0.09 0.25 ± 0.14 0.05 ± 0.05 136.77 ± 11.68
1 mg/kg MWCNT 247.4 ± 20.77 22.0 ± 5.39Ŧ 0.50 ± 0.25Ŧ 0.66 ± 0.35 2.55 ± 1.90 273.17 ± 21.58
2 mg/kg MWCNT 230.75 ± 52.41 18.85 ± 1.78Ŧ 2.35 ± 1.24Ŧ 1.55 ± 1.03 0.10 ± 0.10 253.60 ± 54.36.
4 mg/kg MWCNT 331.62 ± 61.92** 59. 54 ± 6.34** 16.17 ± 3.90** 2.87 ± 1.67 1.24 ± 0.67 441.28 ± 68.13**
Values are mean ± SEM. N = 6/group; *p < 0.01 vs vehicle; **p < 0.001 vs vehicle, Ŧp < 0.05 vs 4 mg/kg MWCNT
Figure 3 Increased collagen content in lung tissue of MWCNT
exposed C57BL/6 mice. Collagen content was determined by lung
tissue harvested from mice 30 days post-exposure to vehicle control
(10% surfactant in saline) or MWCNTs (1, 2, or 4 mg/kg). Mice exposed
to the high dose MWCNT (4 mg/kg) displayed significant increase in
collagen levels compared to naïve mice. All values are expressed as
mean ± SEM (n = 6-11). *p < 0.05 compared to naïve mice and + p <
0.05 compared between two groups. No significant differences were
found between naïve and vehicle treated groups. In addition,
differences between vehicle and treatment groups were not significant.
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the lungs of mice and rats has been shown to induce fibro-
sis [18]; however, extensive evaluation of pulmonary func-
tion changes in animals instilled with MWCNTs has not
been reported. In this study, we demonstrated that 30 days
following MWCNT instillation, C57BL/6 mice exhibited
changes in pulmonary function that were consistent with
pulmonary inflammation, increased collagen deposition and
granuloma formation. Additionally, increased levels of Ccl3,
Ccl11, and Mmp13 were observed in C57BL/6 mice
instilled with different doses of MWCNTs. Taken together,
these results suggest that MWCNT exposure could lead to
impaired pulmonary function due to inflammatory and
fibrotic remodeling of lung tissue.
Due to the implication that MWCNTs may adversely
affect human health and safety, appropriate dosing of
animals was essential to evaluate the pertinence of these
findings in regard to human exposure levels. Studies
conducted in industrial plants indicated nanoparticle
exposure levels up to 0.5 mg/m3 for an 8-hour work day
and 40-hour work week [19]. Additional evaluations of
carbon nanotubes in manufacturing and research facil-
ities, found airborne levels during handling to be as low
as 53 μg/m3 [20] and as high as 400 μg/m3 [4,15]. Shve-
dova et al., report that human occupational exposure
levels of 5 mg/m3 over the course of an 8-hour day and
40-hour work week equate to approximately 20 μg of
Figure 4 Histopathology of lungs exposed to MWCNT displays granulomatous and fibrotic tissue at 30 days post-exposure. Mice
instilled with (A) 10% saline in surfactant vehicle control display normal lung morphology while mice instilled with (B) 4 mg/kg MWCNTs exhibit
widely dispersed deposition of MWCNT aggregates within lung tissue. Masson’s trichrome staining shows collagen rich granulomas and
surrounding fibrotic tissue (blue) in lungs of mice exposed to (D) MWCNTs, but not (C) vehicle control. H&E staining demonstrates
granulomatous peribronchioloar foci in lungs of mice exposed to MWCNT (F) but not vehicle (E). Agglomerates of MWCNT within granulomas
are indicated by arrows. Images are representative of 4 mice per group with original magnifications of 25 × (A-B), 200 × (C-D) and 400 × (E-F).
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MWCNT aspiration in a mouse model [21]. Current
proposed guidelines by the National Institute for
Occupational Safety and Health (NIOSH) limits expo-
sure to 7 μg/m3, the lowest detectable level of airborne
CNT using the latest analytical methods [22]. The
doses used in this study, 1, 2 and 4 mg/kg MWCNTs
(equivalent to 27, 54, and 108 μg of MWCNT in the
average 27 g mouse used in this study), were selected
based on these limited exposure studies and doses pre-
viously reported in the literature for rodent studies [4].
Furthermore, the MWCNTs were dispersed in 10%
surfactant in saline, a physiologically relevant medium,
shown to effectively reduce aggregation of nanotubes
in solution [23]. Data from this study demonstrated a
persistent inflammatory response and the development
of granulomatous and collagen-rich fibrotic tissue in
C57BL/6 mice, similar to previously reported findings
[4,7]. Post-exposure to MWCNTs at 90 days exhibited
granulomatous foci similar to those found in chronic
human granulomatous disorders [24]. In fact, due to
their ability to produce a robust granulomatous
response, the use of MWCNTs has been proposed as a
novel murine model to study chronic granulomatous
disease [24]. In the present study, we demonstrated
that focal aggregates of MWCNTs were present at the
core of the granulomas and surrounding fibrotic tissue
(Figure 4D). In addition, our data indicated that intact
MWCNTs do not congregate to form airway granulo-
mas, but are dispersed throughout the lung tissue (Fig-
ure 4B) contrary to reports from previous investigators
[17]. Furthermore, studies have shown that MWCNTs
are not only found in the periphery of the lungs post-
exposure, but have also been found to translocate to
the pleural space [7]. Data from this study are consis-
tent with previous reports that MWCNTs induce pul-
monary inflammation and fibrosis, and are widely
distributed through the lung following exposure.
Further, we have now shown that these severe adverse
Figure 5 Impaired pulmonary function as determined by Snapshot and Quick-prime 3 perturbation after MWCNT instillation. The
Snapshot and Quick-prime3 perturbations were performed in tracheotomized C57BL/6 mice instilled with increasing doses of MWCNTs. Since
Snapshot perturbation measures the lung as a single compartment, the parameters, R (A), E (B), and C (C), are indicative of the whole respiratory
system including lung and chest wall. On the other hand, Quick-prime 3 perturbation measures the lung as multiple compartments. The
parameters can differentiate between central airway (Rn (D)) and peripheral lung tissue (G (E) and eta (F)). The mean ± SEM of six mice per
group are shown, *p < 0.05 and ** p < 0.01 compared with the naïve mice, # p < 0.05 and ## p < 0.01 compared with the vehicle control (10%
surfactant in saline) mice; + p < 0.05, ++ p < 0.01, and +++ p < 0.001 compared between two groups. No statistically significant differences were
found between naïve and vehicle treated mice.
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pulmonary responses have a negative impact on pul-
monary function.
In this study, pulmonary functional variables were
evaluated in C57BL/6 mice exposed to different doses of
MWCNTs using the FlexiVent system. The Snapshot
perturbation was imposed to measure resistance (R),
dynamic compliance (C), and elastance (E) of the whole
respiratory system (including airways, lung, and chest
wall). Our data showed that R was significantly
increased at the highest dose of MWCNT with a
concomitant declined in dynamic compliance (C). The
decrease in C is consistent with findings in a bleomycin-
induced model of pulmonary fibrosis in mice [10]. How-
ever, that study did not demonstrate an increase in R.
This discrepancy is likely due to the fact that inflamma-
tion was attenuated by use of cyclophosphamide. Thus,
in our study, the consistent elevation in numbers of
inflammatory cells may have contributed to the
increased R observed. Because R reflects the combined
resistance contributed by both the airways and lung
Figure 6 Impaired pulmonary function as determined by PVr-P perturbation after MWCNT instillation. The PVr-P perturbation was
performed in tracheotomized C57BL/6 mice instilled with vehicle (10% surfactant in saline) or increasing doses of MWCNTs. From PV loops,
perturbation parameters, (A) A, (B) K, (C) Cst, (D) Est, and (E) Area were determined. The mean ± SEM of six mice per group are shown, *p < 0.05
and ** p < 0.01 compared with the naïve mice; # p < 0.05, ## p < 0.01, and ### p < 0.001 compared with the vehicle control mice; ++ p < 0.01
compared between two groups. No statistically significant differences were found between naïve and vehicle treated mice.
Table 2 Lung pro-fibrotic gene expression in MWCNT instilled C57BL/6 mice compared to vehicle control
Gene Description p-Value Fold Change
Mmp13 Matrix metallopeptidase 13 0.0253 7.92
Ccl3 Chemokine (C-C motif) ligand 3 0.0078 3.10
Ccl11 Chemokine (C-C motif) ligand 11 0.0038 2.76
Plau Plasminogen activator, urokinase 0.0461 2.11
Cebpb CCAAT/enhancer binding protein (C/EBP), beta 0.0243 -2.05
Jun Jun oncogene 0.0366 -2.09
Eng Endoglin 0.0007 -2.19
Fasl Fas ligand (TNF superfamily, member 6) 0.0044 -2.20
Smad6 MAD homolog 6 (Drosophila) 0.0004 -2.40
Plg Plasminogen 0.0290 -2.44
Serpina1a Serine (or cysteine) peptidase inhibitor, clade A, member 1a 0.0312 -2.46
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Figure 7 Induction of Ccl3, Ccl11, and Mmp13 in lungs of C57BL/6 mice exposed to MWCNTs. Real-Time PCR analysis was performed in
the left lung of vehicle (10% surfactant in saline), 1 mg/kg, 2 mg/kg, and 4 mg/kg MWCNTs instilled C57BL/6 mice for genes (A) Ccl3, (B) Ccl11,
and (C) Mmp13. The mean ± SEM of six mice per group are shown, # p < 0.05, ## p < 0.01, and ### p < 0.001 compared with the vehicle control
mice; + p < 0.05 compared between two groups.
Figure 8 Increased Ccl3, Ccl11, and activity of Mmp13 in BAL fluid after instillation with MWCNTs. ELISA analysis was performed in the
BAL fluid of vehicle, 1 mg/kg, 2 mg/kg, and 4 mg/kg MWCNT instilled C57BL/6 mice for chemokines (A) Ccl3 and (B) Ccl11. Collagenase activity
in the BAL fluid of vehicle control (10% surfactant in saline) and MWCNT instilled mice was measured using SensoLyte® Mmp13 Assay Kit. (C)
The relative fluorescence units (RFUs) and (D) the reaction velocity of Mmp13 were dose-dependent increased 30 days post-MWCNT instillation.
The mean ± SEM of six mice per group are shown, # p < 0.05 and ## p < 0.01 compared with the vehicle control mice.
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parenchyma, we employed the constant-phase model to
distinguish between central and peripheral respiratory
mechanics and to provide information about the hetero-
geneity of the respiratory response [12].
Tissue damping (G), which reflects parenchymal dis-
tortion, showed a dose-dependent increase in MWCNT
instilled mice which was likely due to inflammatory
infiltrates, as well as granuloma formation in the peri-
bronchiolar and alveolar regions of the lung. Since these
structures account for a major portion of the cross-sec-
tional area of the lung, any obstruction in the distal air-
ways and/or alveolar spaces could contribute to an
increase in R. Furthermore, the decrease in C may sug-
gest that the alveoli are not fully expanding as a result
of alveolar volume reduction which is likely due to
inflammation and/or granuloma formation. This would
reduce the traction normally exerted on the conducting
airways at high lung volume and thereby also contribute
to changes in resistance (R). Similar to Rn, H, a measure
of tissue elastance, also displayed a non-significant trend
towards increased elastance with increasing doses of
MWCNT (data not shown). Tissue elastance is typically
elevated with fibrotic lung disease; but the patchy nature
of the granulomatous/fibrotic lesions seen in this model
may account for the lack of significance. However, eta
(G/H) was dose-dependently increased with MWCNT
instillation and was significantly elevated at the highest
dose, indicating heterogeneity in the combined inflam-
matory and fibrotic responses to MWCNTs. On the
other hand, Rn showed a trend toward dose-dependent
increases that did not reach significance, suggesting that
MWCNTs may have a minor effect on central airways.
In support of this, we observed only minor inflamma-
tion within the central airways. However, this effect,
while small with MWCNTs alone, may explain enhance-
ment of airway responses to methacholine in models of
allergic airway disease by exposure to air pollution [8]
observed in other studies. Along the same line, our
study showed a MWCNT-induced increase in eosinophil
numbers and eotaxin levels (Ccl11) which may also con-
tribute to MWCNT enhancement of allergic airway
disease.
Static compliance (Cst) and the upper portion of the
deflation PV curve (K), parameters derived from PVr-P
maneuvers, declined significantly at the highest dose of
MWCNTs which is typical of fibrotic lung disease. In
contrast to our findings, Kamata et al. [25] reported that
carbon black nanoparticles had no effect on lung com-
pliance. This might be due to the physicochemical dif-
ferences between carbon black nanoparticles and
MWCNTs. A decrease in Cst was also observed in the
vehicle treated mice suggesting that the administration
of high doses of pulmonary surfactant reduces lung
compliance.
Taken together, our pulmonary function findings sug-
gest that MWCNT exposure results predominantly in
peripheral respiratory disease as a result of combined
inflammatory infiltrates and granulomatous/fibrotic par-
enchymal responses, reflected by a decline in pulmonary
function. Consistent with other reports, we observed sig-
nificant granuloma formation with fibrotic content
which likely contributed to restrictive changes in
Figure 9 Induction of IL-33 gene and protein expression in C57BL/6 lung tissue and BALF 30 days post-exposure to MWCNTs. Gene
expression of IL-33 (A), determined by Real-Time PCR, demonstrated an approximate three-fold increase in left lung tissue of mice instilled with
MWCNTs compared to vehicle control mice. Correspondingly, ELISA protein analysis (B) of IL-33 in BALF of mice exposed to MWCNTs was also
significantly increased at all doses (1, 2, and 4 mg/kg) compared to vehicle control (10% surfactant in saline). All values are expressed as mean ±
SEM (n = 6-11). #p < 0.05 compared to vehicle control mice and ### p < 0.001 compared with the vehicle control mice.
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pulmonary function [24]. Translocation and penetration
of MWCNTs into pleural space, as previously shown,
may also contribute to peripheral respiratory injury and
subsequent structural changes [7,26].
To begin examining potential molecular mechanisms
by which MWCNT instillation mediates impaired pul-
monary function, gene and protein expression of cyto-
kines and chemokines were examined to identify fibrotic
and inflammatory responses. PCR arrays were utilized to
identify changes in gene expression related to the devel-
opment of fibrosis. We identified Mmp13, Ccl3, and
Ccl11 as three highly upregulated gene products. Mmps
can be divided by structure and substrate specificity into
several subgroups including collagenases, gelatinases,
stromelysins, and membrane-type (MT) Mmps [27].
Imbalanced expression of MMPs has been associated
with fibrosis [28]. Mmp13, an interstitial collagenase, is
considered a key activator in the cascade of proinflam-
matory reactions leading to pulmonary fibrosis [29].
Furthermore, activation of Mmp13 enhances the process
of macrophage chemoattraction and infiltration of other
inflammatory cells following tissue injury. MWCNT
instilled mice exhibited a dose dependent increase in
Mmp13 production and activity in BAL fluid. Addition-
ally, Ccl3 (also named MIP-1a) is a critical macrophage
chemoattractant in murine wound repair [30]. In our
study, increased Ccl3 expression in the lung and
Mmp13 activity in BAL fluid following MWCNT expo-
sure are likely associated with the collagen deposition
and granuloma formation in mouse lung exposed to
MWCNT. Lastly, Ccl11, involved in eosinophil recruit-
ment, was significantly increased in the lung following
MWCNT instillation. This likely contributed to the
increasing trend in eosinophils in the BALF seen with
increasing doses of MWCNT. Consistent with previous
studies [31], an influx of eosinophils into the lungs by a
variety of eosinophil chemoattractants, such as Ccl11,
was observed. This classic Th2 driven inflammatory
response may contribute to the subsequent fibrotic out-
come and change in resistance that was observed in
response to MWCNT exposure.
Finally, IL-33 was examined for its potential role in
inflammatory cell recruitment and Th2 immune
responses following MWCNT exposure. IL-33 is a
member of the IL-1 cytokine family and the only known
ligand for the ST2 receptor [32]. The ST2 receptor is
most highly expressed on mast cells and Th2 lympho-
cytes, and is known to exist in at least two isoforms; a
transmembrane form and a soluble form which is
cleaved after activation by IL-33 [33]. Haraldsan et al.
describe IL-33, as a potential alarmin, or immune stimu-
lating danger signal during trauma or infection [34,35].
Studies have confirmed IL-33 as a chemoattractant for
human and murine Th2 cells [36]. Furthermore, IL-33
has recently been shown to polarize macrophages to a
M2 phenotype (or alternatively activated macrophages),
resulting in enhanced production of pro-inflammatory
and pro-fibrotic cytokines and chemokines in Th2 dri-
ven pathologies [37]. The IL-33/ST2 axis, known to
influence these Th2 cell types including mast cells,
macrophages and eosinophils, has been recognized in
modulating disease pathologies such as anaphylaxis and
allergic asthma [38]. A study by Mangan et al. demon-
strates that expression of transmembrane ST2 on Th2
cells negatively impacts both pulmonary physiologic and
pathologic responses in an OVA-induced pulmonary
inflammation mouse model. Changes in airways resis-
tance measures, such as PenH, along with pathologic
alterations of pulmonary cell infiltrates and cytokine
profiles in ST2 knock-out mice indicate a role for IL-33
and ST2 receptor in regulating allergic inflammatory
responses [39]. Further, airway hyper-reactivity following
allergen challenge can be attenuated by blockade of the
transmembrane ST2 receptor in BALB/c mice [40].
Thus, during injury or insult to the lung, IL-33 upregu-
lation and activation of ST2 receptors may significantly
impact Th2 driven cell types resulting inflammatory,
fibrotic and physiological changes.
Our data show significant increases in IL-33 expres-
sion with MWCNT exposure compared to vehicle con-
trol, demonstrating a potential role in inflammation and
fibrosis. Mechanistically, the release of chemokines
(CCL3 and CCL11), cytokines (IL-33) and the activation
of MMP13, help to amplify pro-inflammatory and pro-
fibrotic mediators, as well as recruit macrophages, neu-
trophils, and eosinophils into the lung, thereby contri-
buting not only to the pathologic inflammatory and
fibrotic responses, but also the physiologic and func-
tional changes induced by MWCNTs.
Conclusion
In this study, we have demonstrated that MWCNT
instillation results in increased immune cell infiltration,
increased collagen deposition, and a granulomatous
response. Further, we provide evidence of detrimental
lung remodeling exhibited by impaired pulmonary func-
tion; and begin to identify mechanisms of MWCNT-
induced lung remodeling through increased expression
of CCL3, CCL11, MMP13 and IL-33. Given these data
and the increased use of MWCNTs and other nanoma-
terials, we believe further investigation into the toxicity
of these materials is warranted.
Methods
Animals
Male C57BL/6 mice were obtained from Jackson
Laboratories (Bar Harbor, ME, USA) at 9 to 10 weeks of
age. The average weight of the C57BL/6 mice was 27.4
Wang et al. Particle and Fibre Toxicology 2011, 8:24
http://www.particleandfibretoxicology.com/content/8/1/24
Page 10 of 13
± 0.58 g. Mice were randomly assigned to five groups
(6-8 mice/group) which included naïve, vehicle (10%
surfactant in saline), 1 mg/kg, 2 mg/kg, or 4 mg/kg
MWCNTs. Mice received a single dose of MWCNTs by
oropharyngeal aspiration of 1, 2, or 4 mg/kg body
weight of MWCNTs or 10% surfactant in saline as vehi-
cle control, following administration of isoflurane
anesthesia [41]. Clinical grade surfactant (Infasurf) was
kindly provided by ONY company (Amherst, NY, USA).
Pulmonary function testing was performed on mice 30
days post-instillation. Following pulmonary function
measurements mice were euthanized for bronchoalveo-
lar lavage and collection of lung tissue. All animal pro-
cedures were conducted in accordance with the
National Institutes of Health guidelines and approved by
the East Carolina University Institutional Animal Care
and Use Committee. All animals were treated humanely
and with regard for alleviation of suffering.
MWCNT characterization
Commercial grade multi-walled carbon nanotubes were
generously provided by NanoTechLabs, Inc (Yadkin-
ville, NC). We performed transmission and scanning
electron microscopy studies using Hitachi H-9500, S-
4800 microscopes to obtain length, diameter distribu-
tion and elemental composition. Raman spectra were
obtained using Ar+ ion excitation at 514.5 nm coupled
with a Dilor XY triple grating monochromator
equipped with thermoelectric cooled CCD. The surface
area, pore volume and pore size distribution of the
MWCNTs were obtained using a physisorption analy-
zer (Micromeritics ASAP 2010) and derived based on
the Brunauer-Emmett-Teller (BET) equation [42] and
the Barrett-Joyner-Halenda (BJH) method [43]. The
MWCNTs were dispersed in a saline solution contain-
ing 10% surfactant at 2 μg/μl and the mixture was
bath-sonicated (1510R-MTH, Branson Ultrasonics
Corp.) for 45 minutes to obtain a suspension. The
hydrodynamic size distribution, a parameter describing
the effective diameter of a diffusing particle, was char-
acterized using dynamic light scattering (Nanosizer
S90, Malvern Instruments). The zeta potential and iso-
electric point (IEP) are primary indicators for describ-
ing the surface charge and stability of MWCNT
suspension, and were determined using a zeta potential
device (Zeta ZS, Malvern Instruments) with the pH
value of the suspension adjusted from 2 to 7 using
HCl.
Pulmonary function testing
Thirty days following instillation of MWCNTs, all mice
were anesthetized, tracheostomized, and placed on the
FlexiVent system (SCIREQ, Montreal, QC, Canada) for
forced oscillatory measurements. Mice were anesthetized
with tribromoethanol (TBE) (400 mg/kg) and paralyzed
with pancuronium bromide (1 mg/kg) to prevent spon-
taneous breathing. Mice were ventilated with a tidal
volume of 10 mL/kg at a frequency of 150 breaths/min
and a positive end expiratory pressure of 3 cm H2O to
prevent alveolar collapse. Total lung capacity (TLC),
Snapshot, Quickprime-3, and pressure-volume (PV)
loops with constant increasing pressure (PVr-P) were
consecutively performed using the Flexivent system. A
TLC perturbation maximally inflates the lungs to a stan-
dard pressure of 30 cm H2O followed by a breath hold
of typically a few seconds to establish a consistent
volume history. A snapshot perturbation maneuver uses
a three-cycle sinusoidal wave of inspiration and expira-
tion to measure total respiratory system resistance (R),
dynamic compliance (C), and elastance (E). A Quick-
prime-3 perturbation, which produced a broadband fre-
quency (0.5 to 19.75 Hz) over 3 seconds, measures
Newtonian resistance which is a measure of central air-
way resistanc (Rn), inertance (I), tissue damping (G), tis-
sue elastance (H) and hysteresivity (eta). PV loops were
generated between 30 cm H2O to -30 cm H2O pressure
to obtain vital capacity (A), the upper portion of the
deflation PV curve (K), quasi-static compliance (Cst)
and elastance (Est), and the area of PV loop (Area). All
perturbations were performed until three acceptable
measurements with coefficient of determination (COD)
≥ 0.9 were recorded in each individual subject.
BAL and cell differential counts
After measuring pulmonary function parameters, the
right lung of each mouse was lavaged in situ four times
with a specific volume (26.25 mL/kg body weight) of
ice-cold Hanks balanced salt solution (HBSS). The first
aliquot of bronchoalveolar lavage fluid (BALF) was col-
lected separately for cytokine analysis, while aliquots 2-4
were pooled. All BALF was centrifuged at 1000 g for 10
min at 4°C. Total cells from all lavages were pooled and
counted and 20,000 cells were centrifuged using a
Cytospin IV (Shandon Scientific Ltd., Cheshire, UK) and
stained with a three-step hematology stain (Richard
Allan Scientific, Kalamazoo, MI, USA). Cell differential
counts were determined by morphology with evaluation
of 300 cells per slide.
Lung histopathology
Unlavaged left lungs from C57BL/6 mice in each treat-
ment group were inflated with 10% neutral buffered for-
malin fixative for 24-72 hrs. Lung tissue was then cut,
processed, and embedded in paraffin, and 5 μM sections
were mounted on slides. Sections were stained with
hematoxylin and eosin (H&E) or Masson’s trichrome
stain to detect inflammatory, morphological changes
and collagen deposition.
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Sircol collagen assay
Soluble collagen content within total lung was deter-
mined using the Sircol Collagen Assay (Biocolor, Belfast,
UK). Lavaged right lung was collected and homogenized
in 2 mL of RIPA buffer including protease inhibitors.
Supernatants were collected from each sample after cen-
trifugation at 10,000 g for 10 minutes at 4°C. Sircol dye
reagent (1 mL) was added to 50 μL of each sample or
varying concentrations of collagen standard to generate
a calibration curve. Following a 30 min incubation per-
iod, samples were centrifuged at 10,000 g for 10 min-
utes. The collagen-dye precipitate was reconstituted in 1
mL of alkali reagent and absorbance was read at 540
nm and total collagen content was calculated from the
standard curve.
Mouse fibrosis PCR-array
Total RNA from left lung tissue of additional mice was
isolated using a Qiagen RNeasy Mini Kit (Qiagen,
Valencia, CA, USA) according to the manufacturer’s
recommendations. Total RNA (2.5 μg) was reverse-tran-
scribed to cDNA using SABiosciences’s RT2 First Strand
Kit (Qiagen, Frederick, MD, USA) and applied to Mouse
Fibrosis PCR Arrays (Cat.# PAMM-120; 96-well format)
following SABiosciences recommendations. Real-time
PCR were performed in an Applied Biosystems StepO-
nePlus Real-Time PCR System (ABI, Foster City, CA,
USA). Data were interpreted using SABiosciences’ web-
based PCR array analysis tool.
qPCR
Total lung RNA was reverse transcribed using a Quanti-
Tect reverse transcription kit (Qiagen). Quantitative
real-time PCR was performed using QuantiTect primer
assays and SYBR green master mix to verify expression
of Ccl3, Ccl11, Mmp13, and IL-33 found in the mouse
fibrosis PCR-array. An Applied Biosystems StepOnePlus
Real-Time PCR System (ABI) was used to obtain cycle
threshold (Ct) values for target and internal reference
cDNA levels. Target cDNA levels were normalized to
GAPDH, an internal reference, using the equation 2-
[ΔCt], where ΔCt is defined as Cttarget- Ctinternal reference.
Values shown are the average of six independent
experiments.
ELISA and MMP13 Activity Assays
Chemokine (CCL3 and CCL11) and cytokine (IL-33)
levels were quantified in BALF using DuoSet ELISA kits
(R&D Systems, Minneapolis, MN) in accordance with
the manufacturer’s instructions. MMP13 activity assays
were performed using SensoLyte® MMP-13 Assay Kit
(AnaSpec, San Jose, CA). BALF (50 μL) containing
MMP13 was activated with 1 mM 4-aminophenylmercu-
ric acetate (APMA) and the assay was performed
according to the manufacturer’s recommendations.
Fluorescence, resulting from enzyme-mediated conver-
sion of the fluorogenic substrates, was immediately mea-
sured by a Synergy™ HT Multi-Detection Microplate
Reader (BioTek, Winooski, VT) using black, round-bot-
tom 96-well plates (Corning, Corning, NY) and continu-
ously recording data every 5 min for 60 min. The
relative fluorescence unit (RFU) was calculated by sub-
tracting fluorescence in the substrate control well from
all experimental wells. The MMP13 activity of test sam-
ples was calculated as the initial reaction velocity (Vo) in
RFU/min.
Statistical Analyses
All data are presented as means ± SEM and were ana-
lyzed by one-way ANOVA, with differences between
groups assessed using Bonferroni post hoc tests. Graphs
and analysis were performed using GraphPad Prism 5
software (GraphPad, San Diego, CA). Differences were
considered statistically significant at p < 0.05.
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